Skip to content
Review Open access

Immunometabolic Remodeling in Osteosarcopenia: Inflammaging, Mitochondrial Dysfunction, Gut-Derived Metabolites and Therapeutic Opportunities

Aug 2026 · Metabolites · Vol 16, pp. 556 · 0 citations · 113 references
Medicine

TL;DR

This narrative review synthesizes evidence linking inflammaging, immune-cell polarization, mitochondrial dysfunction, nutrient metabolic dyshomeostasis, and gut-derived metabolites to the pathogenesis of osteosarcopenia.

Abstract

Osteosarcopenia—defined as the coexistence of sarcopenia and osteoporosis—is increasingly recognized as a clinically important geriatric syndrome associated with falls, fractures, frailty, disability, and mortality. Beyond the simple coexistence of bone and muscle loss, emerging data suggest that osteosarcopenia may reflect systemic dysregulation of the bone–muscle–immune–metabolic network. In this narrative review, we synthesize evidence linking inflammaging, immune-cell polarization, mitochondrial dysfunction, nutrient metabolic dyshomeostasis, and gut-derived metabolites to the pathogenesis of osteosarcopenia. Multiple pathological processes—including chronic low-grade inflammation, Th17/Treg imbalance, macrophage polarization, oxidative stress, impaired mitophagy, insulin resistance, ectopic fat accumulation, and altered microbial metabolites—may converge to disrupt bone–muscle crosstalk. Notably, direct evidence from osteosarcopenic populations remains limited, and many mechanistic insights are extrapolated from osteoporosis, sarcopenia, and aging models. We further discuss current and emerging therapeutic strategies, including exercise, nutritional interventions, anti-osteoporotic agents, metabolic modulators, mitochondrial-targeted therapies, and gut-directed approaches. Longitudinal cohorts, multi-omics studies, and randomized controlled trials are urgently required to validate immunometabolic biomarkers and develop integrated interventions for osteosarcopenia.

Read PDF

Similar papers

Review Open access Sep 2026

Immunometabolic reprogramming in osteoporosis–osteoarthritis comorbidity: from inflammaging to osteochondral unit degeneration

Osteoporosis (OP) and osteoarthritis (OA) are common and highly co-occurring degenerative bone diseases in the elderly population, and their comorbidity mechanisms cannot be fully explained by traditional factors such as mechanical load, changes in bone mass, or hormonal imbalance. OP is primarily characterized by syst...

Wen-Xiong Li, Jie Liu, Jiao Li et al. · 0 citations
Open access Aug 2026

Osteosarcopenia Revisited: From Mechanisms to Management.

To manage and treat osteosarcopenia, a multimodal approach, such as exercise therapy, nutritional supplementation, and pharmacotherapies, is required, and emerging drugs that positively regulate bone and muscle mass are under development and are expected to contribute to individually optimized care.

Takayoshi Sasako, M. G. Borda, Marc Sim et al. · 0 citations
Review Open access Sep 2026

The Inter-relationship between Sarcopenia and Osteoporosis : Molecular Mechanisms and Therapeutic Interventions.

This narrative review synthesizes current evidence supporting osteosarcopenia as an integrated musculoskeletal syndrome, with a particular focus on biomechanical loading, biochemical crosstalk, and inflammatory signaling.

Jeonghyeon Seo, Sang Hoon Hwang, J. Yoon et al. · 0 citations
Review Open access Sep 2026

Bone Aging and Glycative Stress: Convergent and Divergent Mechanisms Driving Skeletal Deterioration

Combined strategies incorporating senolytic, antiglycative, and mechanoprotective approaches—alongside lifestyle interventions—may be needed to more effectively reduce fracture risk in aged and diabetic populations.

Salvador Peñarrubia, E. Martín-Guerrero, A. Gortázar et al. · 0 citations
Review Sep 2026

The triad of muscle health: gut–muscle axis in the context of sarcopenia and exercise, a narrative review

Key mechanistic evidence demonstrating how targeted GM interventions and structured exercise regimens may synergistically counteract muscle decline is explored, to support the development of innovative therapeutic approaches combining exercise and GM modulation to improve muscle health, functional independence, and hea...

Ana Sofia Merelim, Ângelo P. Santos, Rodrigo Zacca et al. · 0 citations
Review Open access Sep 2026

Macrophage immunometabolism in osteoporosis: an emerging regulatory axis linking metabolic–polarization coupling to therapeutic targets

Osteoporosis has long been understood, and treated, as an imbalance between osteoblastic bone formation and osteoclastic resorption. Yet many patients continue to lose bone, pointing to upstream regulators of the remodeling unit that remain poorly defined. Macrophages are developmentally continuous with osteoclasts and...

Lian Weng, Qian-Li Yuan, T. Mo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.